Mirae Asset Global ETFs Holdings
STRO icon

Mirae Asset Global ETFs Holdings’s Sutro Biopharma STRO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
+7,313
New +$228K ﹤0.01% 2387
2025
Q2 		– Sell
-4,900
Closed -$31.9K – 3226
2025
Q1 		$31.9K Buy
4,900
+211
+4% +$3.32K ﹤0.01% 2920
2024
Q4 		$86.3K Buy
4,689
+206
+5% +$6.29K ﹤0.01% 2758
2024
Q3 		$155K Buy
4,483
+1,392
+45% +$54.6K ﹤0.01% 2495
2024
Q2 		$90.6K Buy
+3,091
New +$122K ﹤0.01% 2604

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's STRO Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Sutro Biopharma (STRO) in Q2 2026: 7,313 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #2387 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in STRO as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in STRO in Q2 2024 and has held it in 5 quarters since. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 7,313 shares of Sutro Biopharma worth $243K as of Q2 2026.
  • Sutro Biopharma was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Sutro Biopharma made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2387 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Sutro Biopharma in Q2 2024 and has held it in 5 quarters since.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.